.png){kind=icon}
返回
P
Paul Sargos
Institut Bergonié
35H指数
384论文数
5.1K被引数
收录论文 148
发表时间
.png){kind=icon}
Reply to Federico Iori, Emanuele Alì, and Cinzia Iotti’s Letter to the Editor re: Nicolas Demogeot, Paul Sargos, Julia Salleron, et al. Short-term Androgen Deprivation Therapy and High-dose Radiotherapy in Intermediate- and High-risk Localized Prostate Cancer: Results from the GETUG 14 Randomized Phase 3 Trial. Eur Urol. In press. https://doi.org/10.1016/j.eururo.2025.07.019回复Federico Iori、Emanuele Alì和Cinzia Iotti的致编辑信：关于Nicolas Demogeot、Paul Sargos、Julia Salleron等人关于局部中高危前列腺癌短期雄激素剥夺疗法与高剂量放疗的研究：GETUG 14随机III期试验结果。欧洲泌尿学杂志。待发表。https://doi.org/10.1016/j.eururo.2025.07.019.png)
European Urology.png)
European UrologyIF25.2
PREAI
.png){kind=icon}
分享.png){kind=icon}
收藏Reply to Mattia Longoni, Giorgio Gandaglia, and Francesco Montorsi’s Letter to the Editor re: Nicolas Demogeot, Paul Sargos, Julia Salleron, et al. Short-term Androgen Deprivation Therapy and High-dose Radiotherapy in Intermediate- and High-risk Localized Prostate Cancer: Results from the GETUG 14 Randomized Phase 3 Trial. Eur Urol. In press. https://doi.org/10.1016/j.eururo.2025.07.019回复Mattia Longoni、Giorgio Gandaglia和Francesco Montorsi致编辑的信：关于Nicolas Demogeot、Paul Sargos、Julia Salleron等人关于局部中高风险前列腺癌短期雄激素剥夺疗法联合高剂量放疗的研究结果——GETUG 14随机III期试验的结果。欧洲泌尿学杂志。待发表。https://doi.org/10.1016/j.eururo.2025.07.019European Urology
European UrologyIF25.2
PREAI
分享收藏